Perihan Mir
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Comparison of Gene-Editing Approaches for Severe Congenital Neutropenia-Causing Mutations in the ELANE Gene.
Journal: The CRISPR journal
Published: October 22, 2024
Correction: NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells.
Journal: Stem cell research & therapy
Published: October 20, 2023
CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 29, 2023
Corrigendum to 'Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation' <[Experimental Hematology, Volume 71, 2019;71:51-60]>.
Journal: Experimental hematology
Published: August 11, 2022
A topological refactoring design strategy yields highly stable granulopoietic proteins.
Journal: Nature communications
Published: May 29, 2020
NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells.
Journal: Stem cell research & therapy
Published: April 21, 2020
Gene Knockout in Hematopoietic Stem and Progenitor Cells Followed by Granulocytic Differentiation.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 02, 2020
Design of novel granulopoietic proteins by topological rescaffolding.
Journal: PLoS biology
Published: December 02, 2019
New insights into the pathomechanism of cyclic neutropenia.
Journal: Annals of the New York Academy of Sciences
Published: April 09, 2019
Last Updated: 09/26/2026